ClinicalTrials.Veeva

Menu

The Relationship Between Vitamin D and Hepatitis B Virus Replication

B

Buddhist Tzu Chi Medical Foundation

Status

Completed

Conditions

Vitamin D and Hepatitis B Virus

Treatments

Dietary Supplement: Vitamin D

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

149 HBV carriers with inadequate serum vitamin D levels were randomized to two groups: one is supplied with vitamin D and another without as controls. The markers of HBV replication were compared before and after treatment.

Full description

This is a randomized case-control trial. A total of 149 HBV carriers with inadequate vitamin D (< 30 ng/mL) level were enrolled. They were randomly divided to two groups: one group receiving vitamin D supplement (1600 IU/day) for 2 months and another group as controls. The serum vitamin D, HBV DNA and qHBsAg levels were measured at baseline and after vitamin D supplement. Whether HBV DNA and qHBsAg have significant change after vitamin D supplement can be determined.

Enrollment

149 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >20 y/o, HBV carrier
  • serum vitamin D < 30ng/ml

Exclusion criteria

  • Other known causes of hepatitis

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

149 participants in 2 patient groups

Vitamin D group
Experimental group
Description:
Patients receiving vitamin D supplement (2000 IU/day) for 2 months
Treatment:
Dietary Supplement: Vitamin D
Control group
No Intervention group
Description:
Patients without receiving vitamin D supplement

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems